CELL AND GENE THERAPY INSIGHTS

Cell Therapy Quality/ CMC & Analytics

January 2019
Cell Therapy Quality/ CMC & Analytics
Download PDF

Expert Insight

Standards Landscape in Cell Counting: Implications for Cell & Gene Therapy

Standards Landscape in Cell Counting: Implications for Cell & Gene Therapy

S Sarkar, L Pierce, S Lin-Gibson et al.
15 February 2019
Read
Using Machine Learning for Critical Quality Attribute Discovery in Cell Therapy Manufacture

Using Machine Learning for Critical Quality Attribute Discovery in Cell Therapy Manufacture

Dan Charles Wilkinson, Stefan Irion
14 February 2019
Read
How to Reduce the Vein to Vein Timeframe Through Efficient, Accelerated QC & Release Testing

How to Reduce the Vein to Vein Timeframe Through Efficient, Accelerated QC & Release Testing

Adrian P Gee
14 February 2019
Read

Perspective

An Academic Model for Cell & Gene Therapy Asset Development

An Academic Model for Cell & Gene Therapy Asset Development

David DiGiusto
14 February 2019
Read

Interview

Critical considerations & common mistakes in early-phase CMC development

Critical considerations & common mistakes in early-phase CMC development

Jason Carstens
18 February 2019
Read
European regulator’s perspective: best practice & future directions in cell therapy CMC

European regulator’s perspective: best practice & future directions in cell therapy CMC

Margarida Menezes Ferreira
15 February 2019
Read
Next steps in MSC cell therapy characterization

Next steps in MSC cell therapy characterization

Bruce Bunnell
15 February 2019
Read
Optimizing quality & compliance for cord blood-derived cells

Optimizing quality & compliance for cord blood-derived cells

Roger Horton, Chris Leonforte
15 February 2019
Read